This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date.
When we launched this resource in May 2019, companies with quarterly revenue in excess of US$2.5 million qualified.
We note that often operating income can include one-time items like stock compensation, inventory write-downs or public listing expenses, and we recommend that readers understand how these non-cash items can impact quarterly financials.
Revenue fell 2% sequentially and rose just 20% from a year ago as the company reported an operating loss in excess of $25 million.
Analysts expect Columbia Care revenue to increase 86% to $141 million with adjusted EBITDA of $32 million and Ascend wellness to report revenue of $89 million with adjusted EBITDA of $20 million.
Both GrowGeneration and Hydrofarm, which have done a significant amount of acquisitions, have pre-announced disappointing quarters.
Canopy Growth saw weakness in almost all of its segments in its fiscal Q3, but U.S.
In the first half of March, Valens are reporting from the junior list.
For our readers who are interested in staying on top of scheduled earnings calls in the sector, we have have created and continually update the Cannabis Investor Earnings Conference Call Calendar.